PKO Investment Management Joint Stock Co Purchases Shares of 3,000 Cardinal Health, Inc. $CAH

PKO Investment Management Joint Stock Co purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 3,000 shares of the company’s stock, valued at approximately $471,000.

Several other large investors have also recently made changes to their positions in the stock. Norges Bank acquired a new stake in Cardinal Health in the 2nd quarter valued at approximately $584,420,000. Acadian Asset Management LLC lifted its stake in Cardinal Health by 92.5% during the second quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after purchasing an additional 807,063 shares in the last quarter. Prudential Financial Inc. boosted its position in shares of Cardinal Health by 476.8% during the second quarter. Prudential Financial Inc. now owns 883,348 shares of the company’s stock worth $148,402,000 after buying an additional 730,209 shares during the period. Voya Investment Management LLC grew its stake in shares of Cardinal Health by 298.3% in the third quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after buying an additional 615,398 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC acquired a new stake in shares of Cardinal Health in the second quarter valued at $79,963,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently issued reports on CAH. Robert W. Baird set a $232.00 target price on Cardinal Health in a research note on Friday, October 31st. UBS Group boosted their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research note on Friday, October 31st. Mizuho set a $222.00 price target on shares of Cardinal Health in a research report on Monday. Argus raised their price objective on shares of Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Finally, Evercore ISI lifted their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a report on Friday, October 31st. Fourteen analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $214.07.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal raised FY‑2026 EPS guidance to at least $10, cited accelerating specialty revenue (>$50B target) and announced strategic wins (IRA transition, new ContinuCare™ Pathway and a Publix partnership) — the core catalyst cited by management at J.P. Morgan. PR Newswire: Cardinal Health Raises Fiscal 2026 Outlook
• Positive Sentiment: Major business-media pieces note the guidance raise and specialty growth narrative as the reason for the stock jump and upgraded investor sentiment. Benzinga: Cardinal Health Lifts 2026 Profit Outlook
• Positive Sentiment: Barron’s explained why the guidance lift and specialty revenue trajectory make 2026 a constructive year for the stock, reinforcing buy‑side interest. Barron’s: Cardinal Health Stock Jumps on Guidance Raise
• Neutral Sentiment: The company’s full J.P. Morgan presentation/transcript provides detail on strategy execution and was used to support the guidance update; useful for modeling but not new on the headline guidance. Seeking Alpha: J.P. Morgan Presentation Transcript
• Neutral Sentiment: Analyst coverage and fair‑value views are shifting upward as sell‑side models incorporate the stronger FY26 guide and specialty momentum. Yahoo Finance: Analyst Upgrades & Specialty Focus
• Negative Sentiment: Short interest rose materially in December (≈23.6% increase to ~6.06M shares), which can add downside risk or volatility if sentiment reverses. (No article link provided)
• Negative Sentiment: Some commentary questions valuation after a multi‑year run and steep share gains — investors should weigh the beat/guidance versus premium multiples. Yahoo Finance: Has Cardinal Health Run Too Far?

Cardinal Health Price Performance

CAH stock opened at $208.08 on Wednesday. Cardinal Health, Inc. has a 1 year low of $119.92 and a 1 year high of $214.93. The firm has a market capitalization of $49.44 billion, a P/E ratio of 31.38, a P/E/G ratio of 1.47 and a beta of 0.65. The business’s 50-day moving average is $204.54 and its two-hundred day moving average is $173.77.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.